Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Osveh Pharmaceutical Company is a prominent Iranian pharmaceutical manufacturer headquartered in Tehran, established in 1966. The company specializes in the development and production of a diverse range of therapeutic products, with a particular emphasis on high-tech medicines for multiple sclerosis, oncology, and cardiovascular health. As a subsidiary of the Tamin Pharmaceutical Investment Company (TPICO), Osveh operates advanced manufacturing facilities that comply with international GMP standards. Their portfolio includes well-known brands such as Osvemer and Osvefix, which have significantly improved patient access to critical treatments in the region. The company continues to invest in research and development to expand its offerings in biotechnology and specialized generic medications. Osveh is recognized for its role in the domestic production of complex molecules, reducing reliance on imported pharmaceuticals.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Osveh Pharmaceutical.